Vernal Keratoconjunctivitis: Immunopathological Insights and Therapeutic Applications of Immunomodulators
Vernal keratoconjunctivitis (VKC) is a complex and multifactorial disease process that employs Th2 cell-mediated immunologic processes, which involves the overexpression of interleukin 4 (IL-4), IL-5, IL-9, IL-13, and IL-31, and the activation of mast cells that release IL-5 and CCL-11, recruiting e...
Main Authors: | Navpreet K. Hehar, DeGaulle I. Chigbu |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2024-03-01
|
Series: | Life |
Subjects: | |
Online Access: | https://www.mdpi.com/2075-1729/14/3/361 |
Similar Items
-
Immunopharmacology in Vernal Keratoconjunctivitis: Current and Future Perspectives
by: DeGaulle I. Chigbu, et al.
Published: (2021-07-01) -
Cytokines in Allergic Conjunctivitis: Unraveling Their Pathophysiological Roles
by: DeGaulle I. Chigbu, et al.
Published: (2024-03-01) -
Vernal keratoconjunctivitis
by: Addis H, et al.
Published: (2018-01-01) -
A Case of Shield Ulcer Due to Vernal Keratoconjunctivitis
by: Dilek Özkaya, et al.
Published: (2021-08-01) -
Vernal keratoconjunctivitis and eosinophilic esophagitis: A rare combination?
by: Maria Cristina Artesani, MD, et al.
Published: (2024-01-01)